5/18/2011

Psoriasis creams based on vitamin D may work by increasing the binding of cathelicidin, a peptide, to DNA and inhibiting inflammation, according to research published in Science Translational Medicine. The finding may lead to medicines that target cathelicidin expression, researchers said.

Full Story:
WebMD

Related Summaries